Search clinical trials for: hydroxychloroquine placebo

Total 53989 results

Shin Kong Wu Ho-Su Memorial Hospital

Terminated

A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma

Sarcoma

Taiwan
Lynn McMahon
Medical Research Council; CRUK Trials unit Glasgow

Unknown

Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia

Leukemia

United Kingdom
Frantisek Duska, MD, PhD
University Hospital Olomouc; University Hospital Pilsen; St. Anne's University... and other collaborators

Terminated

Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial (AZIQUINE-ICU)

COVID-19 | Respiratory Failure

Czechia
Salomeh Keyhani MD
San Francisco VA Health Care System

Suspended

VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL) (VA-REACH)

COVID-19 | SARS-CoV-2

United States
Mahidol University

Recruiting

Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection (IDRA-COVID19)

SARS-CoV2 Infection | Asymptomatic Infections

Thailand
Abramson Cancer Center at Penn Medicine
Pfizer

Terminated

TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC) (TACE-Ax-HCQ)

Colorectal Neoplasms Malignant

United States
Taiwan Liposome Company

Completed

The Safety, Tolerability, and Pharmacokinetics of Inhaled TLC19 in Healthy Volunteers

COVID-19

Taiwan
Cairo University

Completed

COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience

Covid19 | Diarrhea

Egypt
Abramson Cancer Center of the University of Pennsylvania

Completed

Dabrafenib, Trametinib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma (BAMM)

Advanced BRAF Mutant Melanoma

United States
Royal College of Surgeons in Ireland - Medical...
Ebrahim Khalil Kanoo Community Medical Center; Hereditary blood Disorder Centre... and other collaborators

Completed

Favipiravir vs Hydroxychloroquine vs Control in COVID -19

COVID-19 | SARS-CoV 2

Bahrain
Almaza Military Fever Hospital

Completed

Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment

Covid19

Egypt
Roberto Poscia MD, PhD

Unknown

Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora (PROBIOZOVID)

Coronavirus Infection | Pneumonia, Viral | SARS-CoV 2 | COVID

Italy
Peking Union Medical College Hospital

Unknown

Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy (HCQIgAN)

Primary IgA Nephropathy

China
Corpometria Institute

Not yet recruiting

The (HD)IVACOV Trial (The High-Dose IVermectin Against COVID-19 Trial)

Covid19
Nathan Bahary, MD
National Cancer Institute (NCI); Pfizer

Terminated

Pre-Operative Trial (PGHA vs. PGH) for Resectable Pancreatic Cancer (17-134)

Pancreatic Cancer Resectable

United States
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Insulin Receptor Substrate 1 (IRS-1) Regulation in Insulin Resistance

Type 2 Diabetes Mellitus

United States
Shanghai Children's Hospital

Recruiting

Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS) (CHXLAS)

Alport Syndrome, X-Linked

China
Abramson Cancer Center of the University of Pennsylvania

Completed

A Phase I/II/Pharmacodynamic Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane to Inhibit Autophagy in Pancreatic Cancer

Metastatic Adenocarcinoma | Advanced Adenocarcinoma

United States
University of Milano Bicocca
Agenzia Italiana del Farmaco

Completed

Hydroxychloroquine as Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS). (HySSAS)

Pulmonary Sarcoidosis

Italy
Incannex Healthcare Ltd

Recruiting

Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis (CHAPPII)

Rheumatoid Arthritis

Australia
Maimónides Biomedical Research Institute of Córdoba

Recruiting

Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19 (AMBUCOV)

Covid19 | Acute Respiratory Distress Syndrome

Spain
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Active, not recruiting

Testing Dabrafenib and Trametinib With or Without Hydroxychloroquine in Stage IIIC or IV BRAF V600E/K Melanoma

Locally Advanced Melanoma | Unresectable Melanoma | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8

United States
Karolinska Institutet
Harvard Medical School (HMS and HSDM)

Completed

Real-World Emulation of the SWEFOT Trial (SWEFOT-RWEM)

Rheumatoid Arthritis

Sweden
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
Heinrich-Heine University, Duesseldorf
Universitätsklinikum Hamburg-Eppendorf; University Hospital Frankfurt; St. Georg... and other collaborators

Withdrawn

Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19 (CLOCC)

COVID
University of Calgary

Recruiting

Hydroxychloroquine and Indapamide in SPMS

Multiple Sclerosis, Secondary Progressive

Canada
Sanjay Gandhi Postgraduate Institute of Medical...

Completed

Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back Pain

Seronegative Spondyloarthropathies

India
Ain Shams University

Not yet recruiting

Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss

Recurrent Pregnancy Loss
Peng Wang, MD PhD

Completed

Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors

Solid Tumor

United States
Istituto Scientifico Romagnolo per lo Studio e...
University of Bologna

Active, not recruiting

Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19) (PROTECT)

SARS-CoV-2 | COVID19 | Treatment | Prophylaxis | Hydroxychloroquine

Italy
Bryn Mawr Hospital
Sharpe-Strumia Research Foundation; Bryn Mawr Hospital Foundation; Cotswold Foundation

Completed

Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts

Coronavirus Infection | Covid19 | Transmission | Prophylaxis | Hydroxychloroquine

United States
Assiut University

Completed

Antimalarial and Covid 19 in Rheumatoid Arthritis

Rheumatoid Arthritis

Egypt
Assiut University

Unknown

Hydroxychloroquine Efficacy on Behcet's Disease Thrombosis

Behcet's Syndrome, Vascular Type

Egypt
Center for Primary Care and Public Health (Unisante)...

Suspended

#StayHome: Early Hydroxychloroquine to Reduce Secondary Hospitalisation and Household Transmission in COVID-19 (#StayHome)

COVID-19

Switzerland
Washington University School of Medicine

Terminated

Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection (WU352)

Coronavirus Infection

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Recruiting

PHL Treatment in Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma

United States
Henan Cancer Hospital

Not yet recruiting

Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer

Lung Neoplasms | Gemcitabine | Hydroxychloroquine
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Randomized Controlled Trial of Hydroxychloroquine Combined With Low-dose Corticosteroid in Pulmonary Sarcoidosis (QUIDOSE)

Pulmonary Sarcoidosis
University of New Mexico

Terminated

Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19

COVID-19

United States
Samah Lutfy

Unknown

Hydroxychloroquine in COVID-19 Patients

COVID-19

Saudi Arabia
Shanghai Public Health Clinical Center

Completed

Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19

COVID-19 | Coronavirus | Pneumonia, Pneumocystis

China
St Stephens Aids Trust

Unknown

Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART) (SSAT039)

HIV Infection

United Kingdom
Hordinsky, Maria K., MD

Completed

Plaquenil for Alopecia Areata, Alopecia Totalis

Alopecia Areata

United States
Peking Union Medical College Hospital
Eli Lilly and Company

Recruiting

Efficacy and Safety of Baricitinib in Sjogren's Syndrome

Sjogren's Syndrome

China
Universidad Peruana Cayetano Heredia

Completed

Hydroxychloroquine to Prevent SARS-CoV-2 Infection/COVID-19

SARS-CoV-2

Peru
Rambam Health Care Campus

Unknown

Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers

Coronavirus Disease 2019 (COVID-19) | Post-Exposure Prophylaxis

Israel
VA Office of Research and Development

Completed

Management of Cardiovascular Disease in Kidney Disease (MaCK) Study (MaCK)

Inflammation | Cardiovascular Disease | Atherosclerosis | Chronic Kidney Disease | Aortic Stiffness

United States
Yaounde Central Hospital

Unknown

Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19 (DOXYCOV)

COVID-19

Cameroon
BioXcellerator
Clinical Somer

Recruiting

Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19

Acute Respiratory Distress Syndrome

Colombia
University Hospital, Toulouse

Not yet recruiting

Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients (HCQMa)

Mastocytosis

France

Search clinical trials for: hydroxychloroquine placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations